Icosavax Inc (DELISTED) (ICVX:DL)
15.31
0.00 (0.00%)
USD |
NASDAQ |
Feb 29, 16:00
Icosavax Cash from Operations (Quarterly): -18.97M for Sept. 30, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -18.97M |
| June 30, 2023 | -19.22M |
| March 31, 2023 | -21.65M |
| December 31, 2022 | -11.63M |
| September 30, 2022 | -17.38M |
| June 30, 2022 | -15.20M |
| March 31, 2022 | -17.46M |
| December 31, 2021 | -13.04M |
| Date | Value |
|---|---|
| September 30, 2021 | -9.326M |
| June 30, 2021 | -12.00M |
| March 31, 2021 | -4.182M |
| December 31, 2020 | -3.688M |
| September 30, 2020 | -2.437M |
| June 30, 2020 | -4.54M |
| March 31, 2020 | -3.543M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-21.65M
Minimum
Mar 2023
-2.437M
Maximum
Sep 2020
-11.62M
Average
-12.00M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| Karuna Therapeutics Inc (DELISTED) | -111.06M |
| Immunogen Inc (DELISTED) | 2.77M |
| AbbVie Inc | 4.04B |
| Assure Holdings Corp | -0.222M |
| Harpoon Therapeutics Inc (DELISTED) | -16.53M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -72.65M |
| Cash from Financing (Quarterly) | -0.208M |
| Free Cash Flow | -76.31M |
| Free Cash Flow Per Share (Quarterly) | -0.3798 |
| Free Cash Flow Yield | -11.32% |